Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

External validation of the preoperative risk evaluation for partial nephrectomy (PREP) score.

BJUI compass·2026
Same author

External validation of the European association of urology biochemical recurrence risk groups to predict mortality after radical prostatectomy or radiation therapy in a North American cohort.

BJUI compass·2026
Same author

Ten Years of Tubes: Characterizing Delays in Definitive Management of Benign Ureteral Obstruction.

Journal of endourology·2026
Same author

HF-125, a first-in-class computer-modeled novel inhibitor of Tribbles 2, for therapy of enzalutamide resistant, neuroendocrine prostate cancer.

bioRxiv : the preprint server for biology·2026
Same author

Cancer-specific mortality differences between radical prostatectomy and radiotherapy after biochemical recurrence: analysis of a health system-wide cohort.

World journal of urology·2026
Same author

The impact of prostate size on single-port robot-assisted radical prostatectomy surgical outcomes.

BJU international·2026

Related Experiment Video

Updated: Jun 5, 2026

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

Robot-assisted partial nephrectomy in obese patients.

Naveed Naeem1, Firas Petros, Shyam Sukumar

  • 1Henry Ford Hospital, Vattikuti Urology Institute, Detroit, Michigan 48202, USA.

Journal of Endourology
|January 6, 2011
PubMed
Summary
This summary is machine-generated.

Robot-assisted partial nephrectomy (RAPN) is safe for obese patients, showing similar complication rates to nonobese individuals. Obese patients experienced slightly higher blood loss but comparable outcomes in this study.

More Related Videos

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Related Experiment Videos

Last Updated: Jun 5, 2026

Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
12:34

Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction

Published on: January 3, 2020

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Obesity Medicine

Background:

  • Obesity is a growing concern in healthcare, impacting surgical outcomes.
  • Robot-assisted partial nephrectomy (RAPN) offers a minimally invasive approach for kidney tumor removal.
  • The safety and efficacy of RAPN in obese populations require further investigation.

Purpose of the Study:

  • To compare the outcomes of robot-assisted partial nephrectomy (RAPN) in obese versus nonobese patients.
  • To evaluate the feasibility and safety of RAPN for kidney cancer in individuals with a BMI ≥ 30 kg/m².
  • To analyze operative data, complications, and pathological results between obese and nonobese cohorts undergoing RAPN.

Main Methods:

  • A retrospective review of 97 patients who underwent RAPN between June 2004 and September 2009.
  • Patients were divided into two groups: obese (BMI ≥ 30 kg/m²) and nonobese (BMI < 30 kg/m²).
  • Demographic, operative, complication, and pathological data were compared between the groups.

Main Results:

  • Obese patients (n=49) had a mean BMI of 36.2 kg/m² compared to nonobese patients (n=48) with a mean BMI of 25.7 kg/m².
  • Obese patients showed a statistically significant increase in median estimated blood loss (150 vs. 100 mL, p=0.027).
  • Trends towards longer operative time and warm ischemia time in obese patients did not reach statistical significance; complication rates and hospital stay were similar.

Conclusions:

  • Robot-assisted partial nephrectomy (RAPN) is a safe and feasible surgical option for obese patients with kidney tumors.
  • While obese patients may experience increased blood loss, RAPN does not lead to significantly higher complication rates.
  • The findings support the use of RAPN as an effective treatment for kidney cancer in the obese population.